152 related articles for article (PubMed ID: 17390625)
21. Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique.
Castellanos IJ; Carrasquillo KG; López JD; Alvarez M; Griebenow K
J Pharm Pharmacol; 2001 Feb; 53(2):167-78. PubMed ID: 11273012
[TBL] [Abstract][Full Text] [Related]
22. Parallel synthesis and high throughput dissolution testing of biodegradable polyanhydride copolymers.
Vogel BM; Cabral JT; Eidelman N; Narasimhan B; Mallapragada SK
J Comb Chem; 2005; 7(6):921-8. PubMed ID: 16283803
[TBL] [Abstract][Full Text] [Related]
23. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
Yang YY; Chia HH; Chung TS
J Control Release; 2000 Oct; 69(1):81-96. PubMed ID: 11018548
[TBL] [Abstract][Full Text] [Related]
24. Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells.
Phanse Y; Carrillo-Conde BR; Ramer-Tait AE; Roychoudhury R; Pohl NL; Narasimhan B; Wannemuehler MJ; Bellaire BH
Acta Biomater; 2013 Nov; 9(11):8902-9. PubMed ID: 23796408
[TBL] [Abstract][Full Text] [Related]
25. Bioadhesive fluorescent microspheres as visible carriers for local delivery of drugs. I: preparation and characterization of insulin-loaded PCEFB/PLGA microspheres.
Jiang HL; Zhu KJ
J Microencapsul; 2002; 19(4):451-61. PubMed ID: 12396382
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of polyanhydride for local BCNU delivery carriers.
Kim MS; Seo KS; Seong HS; Cho SH; Lee HB; Hong KD; Kim SK; Khang G
Biomed Mater Eng; 2005; 15(3):229-38. PubMed ID: 15912003
[TBL] [Abstract][Full Text] [Related]
27. Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.
Castellanos IJ; Al-Azzam W; Griebenow K
J Pharm Sci; 2005 Feb; 94(2):327-40. PubMed ID: 15570602
[TBL] [Abstract][Full Text] [Related]
28. Biodegradable salicylate-based poly(anhydride-ester) microspheres for controlled insulin delivery.
Delgado-Rivera R; Rosario-Meléndez R; Yu W; Uhrich KE
J Biomed Mater Res A; 2014 Aug; 102(8):2736-42. PubMed ID: 24027012
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of poly (1, 6-bis-(p-carboxyphenoxy) hexane-co-sebacic acid microspheres for controlled basal insulin delivery.
Manoharan C; Singh J
Pharm Res; 2013 Mar; 30(3):627-40. PubMed ID: 22975807
[TBL] [Abstract][Full Text] [Related]
30. Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery.
Hanes J; Chiba M; Langer R
Biomaterials; 1998; 19(1-3):163-72. PubMed ID: 9678864
[TBL] [Abstract][Full Text] [Related]
31. Degradation of double-walled polymer microspheres of PLLA and P(CPP:SA)20:80. I. In vitro degradation.
Leach KJ; Mathiowitz E
Biomaterials; 1998 Nov; 19(21):1973-80. PubMed ID: 9863531
[TBL] [Abstract][Full Text] [Related]
32. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin.
Uchida T; Yoshida K; Ninomiya A; Goto S
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1569-73. PubMed ID: 7586084
[TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of biodegradable microspheres containing hepatitis B surface antigen.
Zhou S; Liao X; Liang Z; Li X; Deng X; Li H
Macromol Biosci; 2004 Jan; 4(1):47-52. PubMed ID: 15468287
[TBL] [Abstract][Full Text] [Related]
34. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability.
Manoharan C; Singh J
J Pharm Sci; 2009 Feb; 98(2):529-42. PubMed ID: 18548615
[TBL] [Abstract][Full Text] [Related]
35. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
Cho SW; Song SH; Choi YW
Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
[TBL] [Abstract][Full Text] [Related]
36. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
[TBL] [Abstract][Full Text] [Related]
37. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres.
Fu K; Griebenow K; Hsieh L; Klibanov AM; LangerR
J Control Release; 1999 Apr; 58(3):357-66. PubMed ID: 10099160
[TBL] [Abstract][Full Text] [Related]
38. Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on alpha-chymotrypsin stability upon encapsulation in PLGA microspheres.
Castellanos IJ; Flores G; Griebenow K
J Pharm Pharmacol; 2005 Oct; 57(10):1261-69. PubMed ID: 16259754
[TBL] [Abstract][Full Text] [Related]
39. Preparation and degradation behavior of polyanhydrides nanoparticles.
Lee WC; Chu IM
J Biomed Mater Res B Appl Biomater; 2008 Jan; 84(1):138-46. PubMed ID: 17474078
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Bittner B; Morlock M; Koll H; Winter G; Kissel T
Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]